Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Cited In for PubMed (Select 14693318)

1.

Medication oversupply in patients with diabetes.

Thorpe CT, Johnson H, Dopp AL, Thorpe JM, Ronk K, Everett CM, Palta M, Mott DA, Chewning B, Schleiden L, Smith MA.

Res Social Adm Pharm. 2014 Sep 11. pii: S1551-7411(14)00319-2. doi: 10.1016/j.sapharm.2014.09.002. [Epub ahead of print]

PMID:
25288448
2.

Evolving trends in insulin delivery in pursuit of improvements in diabetes management.

Akhrass F, Skinner N, Boswell K, Travis LB.

Am Health Drug Benefits. 2010 Mar;3(2):117-22.

3.

Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD.

Bhardwaja B, Carroll N, Korner E, Nair KV.

Am Health Drug Benefits. 2009 Sep;2(6):242-50.

4.

Barriers to diabetes medication adherence in North West Ethiopia.

Abebe SM, Berhane Y, Worku A.

Springerplus. 2014 Apr 17;3:195. doi: 10.1186/2193-1801-3-195. eCollection 2014.

5.

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus.

Ascher-Svanum H, Lage MJ, Perez-Nieves M, Reaney MD, Lorraine J, Rodriguez A, Treglia M.

Diabetes Ther. 2014 Jun;5(1):225-42. doi: 10.1007/s13300-014-0065-z. Epub 2014 Apr 30.

6.

Adherence and health care costs.

Iuga AO, McGuire MJ.

Risk Manag Healthc Policy. 2014 Feb 20;7:35-44. doi: 10.2147/RMHP.S19801. eCollection 2014. Review.

7.

Adherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran.

Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M.

Iran J Pharm Res. 2011 Fall;10(4):933-9.

8.

The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control.

Mayberry LS, Gonzalez JS, Wallston KA, Kripalani S, Osborn CY.

Diabetes Res Clin Pract. 2013 Nov;102(2):96-104. doi: 10.1016/j.diabres.2013.09.010. Epub 2013 Sep 26.

9.

The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis.

Sinnott SJ, Buckley C, O'Riordan D, Bradley C, Whelton H.

PLoS One. 2013 May 28;8(5):e64914. doi: 10.1371/journal.pone.0064914. Print 2013. Review.

10.

Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.

Sacks NC, Burgess JF Jr, Cabral HJ, Pizer SD, McDonnell ME.

J Gen Intern Med. 2013 Jul;28(7):876-85. doi: 10.1007/s11606-013-2342-3. Epub 2013 Feb 13.

11.

Evaluation of insulin use and value for money in type 2 diabetes in the United kingdom.

Gordon J, Evans M, McEwan P, Bain S, Vora J.

Diabetes Ther. 2013 Jun;4(1):51-66. doi: 10.1007/s13300-012-0018-3. Epub 2013 Jan 8.

12.

Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.

Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PD.

J Gen Intern Med. 2013 Feb;28(2):208-15. doi: 10.1007/s11606-012-2200-8. Epub 2012 Sep 5.

13.

Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement.

Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, Mauldin PD.

Diabetes Care. 2012 Dec;35(12):2533-9. doi: 10.2337/dc12-0572. Epub 2012 Aug 21.

14.

Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.

Davidoff A, Lopert R, Stuart B, Shaffer T, Lloyd JT, Shoemaker JS.

Value Health. 2012 May;15(3):404-11. doi: 10.1016/j.jval.2012.01.008. Epub 2012 Apr 10.

15.

How patient cost-sharing trends affect adherence and outcomes: a literature review.

Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR.

P T. 2012 Jan;37(1):45-55.

16.

Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.

Bogner HR, Morales KH, de Vries HF, Cappola AR.

Ann Fam Med. 2012 Jan-Feb;10(1):15-22. doi: 10.1370/afm.1344.

17.

Race and medication adherence and glycemic control: findings from an operational health information exchange.

Zhu VJ, Tu W, Marrero DG, Rosenman MB, Overhage JM.

AMIA Annu Symp Proc. 2011;2011:1649-57. Epub 2011 Oct 22.

18.

Antimigraine medication use and associated health care costs in employed patients.

Wu J, Hughes MD, Hudson MF, Wagner PJ.

J Headache Pain. 2012 Mar;13(2):121-7. doi: 10.1007/s10194-011-0405-6. Epub 2011 Nov 30.

19.

Using quantile regression to investigate racial disparities in medication non-adherence.

Gebregziabher M, Lynch CP, Mueller M, Gilbert GE, Echols C, Zhao Y, Egede LE.

BMC Med Res Methodol. 2011 Jun 6;11:88. doi: 10.1186/1471-2288-11-88.

20.

A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.

Gellad WF, Grenard JL, Marcum ZA.

Am J Geriatr Pharmacother. 2011 Feb;9(1):11-23. doi: 10.1016/j.amjopharm.2011.02.004. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk